Sponsor

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Clinical research sponsor

Published trials7
Recruiting shown2
Roles1
SourceClinicalTrials.gov

Clinical trials

7 shown
Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound) in Breast Cancer PatientsNCT07096869 · lead sponsor · 2025-06-26
RECRUITING
A Bioequivalence Study of PP3M in Patients With SchizophreniaNCT07493551 · lead sponsor · 2024-10-09
RECRUITING
A Study Evaluating Aprocitentan Tablets(SYH9108) for the Treatment of Resistant HypertensionNCT07635914 · lead sponsor · 2026-05-31
NOT_YET_RECRUITING
Steady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia.NCT07547384 · lead sponsor · 2026-04-05
NOT_YET_RECRUITING
Bioequivalence Study of Long-Acting Paliperidone Palmitate in Patients With SchizophreniaNCT07268430 · lead sponsor · 2023-12-18
COMPLETED
A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergencyNCT05783557 · lead sponsor · 2023-05-01
UNKNOWN
A Study of Mitoxantrone Hydrochloride Liposome Injection for Relapsing Multiple SclerosisNCT05496894 · lead sponsor · 2022-08-01
WITHDRAWN

Sponsor roles

lead sponsor7

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.